Skip to content

Lung Ultrasound for Physiotherapy in Hospitalized Patients With Respiratory Complications

The Value of Point-of-care Lung Ultrasound for Physiotherapy in Hospitalized Patients With Acute Respiratory Symptoms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06412081
Enrollment
30
Registered
2024-05-14
Start date
2024-05-10
Completion date
2026-12-30
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Complication

Brief summary

This study aims to evaluate the relevance of using point-of-care lung ultrasound (LUS) in modifying the physiotherapist's treatment plan for patients hospitalized in a general ward.

Detailed description

Hospitalized patients often confront respiratory issues stemming from diverse causes, such as pneumonia. Physiotherapists rely on a range of clinical and imaging data to inform their treatment decisions. Yet, they face challenges due to the absence of readily accessible, sensitive, specific, and reliable measurements to tailor the most effective physical therapeutic interventions based on individual clinical scenarios. Point-of-care Lung Ultrasound (LUS) holds promise in addressing these existing gaps. This study aims to evaluate the impact of integrating LUS into clinical practice by comparing physiotherapists' initial clinical assessments and treatment plans with those made after incorporating LUS findings in patients admitted to a general ward.

Interventions

None listed

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Hospitalization in a general ward * Acute respiratory symptoms (\< 48h) * Chest X-ray available within 24h before or after the use of LUS

Exclusion criteria

* Any conditions precluding the use of LUS (thoracic skin lesions, thoracic bandage, subcutaneous emphysema) * Inability to understand instructions due to cognitive impairment or due to language barrier

Design outcomes

Primary

MeasureTime frameDescription
Percentage of change of treatment planBefore and Immediately after the use of LUS (10-min interval)Relative change of treatment plan after the results of LUS in relation to the total number of events

Secondary

MeasureTime frameDescription
Agreement between the events observed on LUS and the events observed on Chest X-RayAt baselineNumber of concordant findings between LUS and Chest X-Ray. Each pair of tests will be rated as "positive" (same findings are observed between LUS and Chest X-Ray) or "negative" (findings are different).

Countries

Belgium

Contacts

CONTACTWilliam Poncin
william.poncin@uclouvain.be+3227642316

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026